Skip to main content
. 2021 Sep;49(9):822–832. doi: 10.1124/dmd.120.000320

TABLE 3.

Summary of incubation conditions and positive controls used in the P450-Glo assays

Enzyme Inhibitor Dilution Format Inhibitor Concentration Incubation Conditions
CYP3A4 Ketoconazole 16 concentrations/2-fold dilution in duplicates 57 µM to 1.8 nM 1 h/RT
CYP2C9 Sulfaphenazole 57 µM to 1.8 nM 1 h/ 37°C/ 0.4% BSA
CYP2D6 Quinidine 1.4 µM to 0.04 nM 1 h/RT